Developing a percutaneously permanent implantable left ventricular assist device to treat heart failure

心血管疾病是英国最常见的死亡原因。心脏病发作后，心脏会变得更虚弱，难以将血液输送到全身。这会导致更少的血液进入肾脏和大脑，虽然患者可以服用药物来帮助，但他们无法使心脏恢复正常，可悲的是，在英国，每年仍有大约6万人死于心力衰竭。这项创新是一种设备，心脏病专家可以相对快速和容易地插入，并与心脏合作，改善器官的血液供应，减少心脏的工作量。它有可能为患者搭建心脏移植的桥梁，甚至让患者与之共处多年。这为心脏提供了恢复的潜力，或者让他们在余生中生活在一起，基本上治愈了他们的终末期心力衰竭。

Cardiovascular disease is the most common cause of death in the UK. After a heart attack, the heart is weaker, and struggles to pump blood around the body. This causes less blood to get to the kidneys and brain and whilst patients can take medications to help, they cannot make the heart return to normal, and sadly approximately 60,000 people in the UK per year still die from heart failure.This innovation is a device which cardiologists can insert relatively quickly and easily and works with the heart to improve the blood supply to the organs, and reduce the workload of the heart. It has the potential to either bridge patients to a heart transplant, or even for patients to live with for many years. This gives the potential for the heart to recover, or for them to live with for the rest of their lives, essentially curing them of end stage heart failure.